FN1 and ovarian cancer: As the TG2-FN interaction plays a role in cell adhesion to the matrix, we postulate that SMIs targeting this complex may be developed into agents that block cancer metastasis, particularly for tumors like ovarian cancer that rely on adhesion to the ECM, as a primary mode of dissemination.